Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

NovaBay Pharmaceuticals, Inc. (NBY)

Pharmaceutical Preparations

https://www.novabay.com

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

2000 POWELL STREET, SUITE 1150
EMERYVILLE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/29/2007

Market Cap

2,565,476

Shares Outstanding

6,530,000

Weighted SO

6,529,302

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

IMMX --.--%

CNSP --.--%

EFTR --.--%

NAVB --.--%

SONN --.--%

ZVSA --.--%

VECT --.--%

AVRO --.--%

ZURA --.--%

Beta

0.8320

Last Div

0.0000

Range

0.36-44.8

Chg

0.0330

Avg Vol

456370

Mkt Cap

2565476

Exch

AMEX

Country

US

Phone

510 899 8800

DCF Diff

0.2967

DCF

2.5868

Div Yield

0.0000

P/S

0.2136

EV Multiple

-0.8565

P/FV

-0.9830

Div Yield %

0.0000

P/E

-0.0569

PEG

-0.0021

Payout

0.0000

Current Ratio

0.6241

Quick Ratio

0.4302

Cash Ratio

0.2080

DSO

16.6199

DIO

51.3671

Op Cycle

67.9870

DPO

90.6263

CCC

-22.6392

Gross Margin

0.5859

Op Margin

-0.3778

Pretax Margin

-0.8774

Net Margin

-0.8877

Eff Tax Rate

-0.0356

ROA

-2.7169

ROE

-4.3113

ROCE

-14.4063

NI/EBT

1.0118

EBT/EBIT

2.3226

EBIT/Rev

-0.3778

Debt Ratio

0.5121

D/E

-3.2577

LT Debt/Cap

2.9587

Total Debt/Cap

1.4429

Int Coverage

-10.6028

CF/Debt

-1.4075

Equity Multi

-6.3614

Rec Turnover

21.9616

Pay Turnover

4.0275

Inv Turnover

7.1057

FA Turnover

10.0443

Asset Turnover

3.0606

OCF/Share

-2.4494

FCF/Share

-2.4563

Cash/Share

0.6502

OCF/Sales

-0.2355

FCF/OCF

1.0028

CF Coverage

-1.4075

ST Coverage

-2.6243

CapEx Coverage

-353.6250

Div&CapEx Cov

-353.6250

P/BV

-0.9830

P/B

-0.9830

P/S

0.2136

P/E

-0.0569

P/FCF

-0.9043

P/OCF

-0.2144

P/CF

-0.2144

PEG

-0.0021

P/S

0.2136

EV Multiple

-0.8565

P/FV

-0.9830

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 18, 22:30 NioBay Applauds Phosphorous Critical Minerals Classification GlobeNewswire Inc. Jun 18, 22:30 Les Métaux NioBay salue l’ajout du phosphore à la liste des minéraux critiques du Canada GlobeNewswire Inc. Jan 18, 07:30 Corporate Update on NioBay Activities GlobeNewswire Inc. Jan 18, 07:30 Mise à jour corporative des activités de NioBay

Revenue Product Segmentation